Literature DB >> 4210505

Glycosphingolipids covalently linked to agarose gel or glass beads. Use of the compounds for purification of antibodies directed against globoside and hematoside.

R A Laine, G Yoggeswaran, S Hakorori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4210505

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  6 in total

1.  Monovalent antibodies directed to transformation-sensitive membrane components inhibit the process of viral transformation.

Authors:  C A Lingwood; A Ng; S Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

Review 2.  Carbohydrate-to-carbohydrate interaction, through glycosynapse, as a basis of cell recognition and membrane organization.

Authors:  Senitiroh Hakomori
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

3.  Affinity isolation of cultured tumor cells by means of drugs and hormones covalently bound to glass and Sepharose beads.

Authors:  B R Venter; J C Venter; N O Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

4.  Production of monoclonal antibodies specific for two distinct steric portions of the glycolipid ganglio-N-triosylceramide (asialo GM2).

Authors:  W W Young; E M MacDonald; R C Nowinski; S I Hakomori
Journal:  J Exp Med       Date:  1979-10-01       Impact factor: 14.307

5.  Shotgun glycomics: a microarray strategy for functional glycomics.

Authors:  Xuezheng Song; Yi Lasanajak; Baoyun Xia; Jamie Heimburg-Molinaro; Jeanne M Rhea; Hong Ju; Chunmei Zhao; Ross J Molinaro; Richard D Cummings; David F Smith
Journal:  Nat Methods       Date:  2010-12-05       Impact factor: 28.547

6.  Putative inhibitory effects of chrysotile, crocidolite, and amosite mineral fibers on the more complex surface membrane glycolipids and glycoproteins.

Authors:  H A Newman; Y A Saat; R W Hart
Journal:  Environ Health Perspect       Date:  1980-02       Impact factor: 9.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.